Quest Diagnostics Inc
DGX: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| m<C | LOCK|$<GG | LOCK|WbjN!fk |
Quest Diagnostics Earnings: Strong Underlying Fundamentals Remain While Lifelabs Adds Topspin
Quest Diagnostics delivered second-quarter revenue and adjusted earnings growth of 15% and 14%, respectively, boosted by the addition of the Lifelabs acquisition.
